comparemela.com

Latest Breaking News On - ப்ரிந்ஸிபல் விஞ்ஞானி - Page 7 : comparemela.com

Dr Virendra Kumar to address National Convention on Digital Best Practices and North East Summit – India Education | Latest Education News | Global Educational News

New Delhi: The National Trust for the Welfare of Persons with Autism, Cerebral Palsy, Mental Retardation and Multiple Disabilities,working for the empowerment of Divyangjan in these categories since 2000 under the aegis of Department of Empowerment o

Govt Polytechnic Kathua organises webinar on Latest Technologies in Manufacturing – India Education | Latest Education News | Global Educational News

JAMMU: Government Polytechnic College Kathua today organized a Webinar for the students of the College on Latest Technologies used in Manufacturing Industry.The resource person for the webinar was Er Anil Kumar Katare, Principal Scientist, CSIR- Qual

National Convention on Digital Best Practices and North East Summit

New Delhi: The National Trust for the Welfare of Persons with Autism, Cerebral Palsy, Mental Retardation and Multiple Disabilities, Department of Empowerment of Persons with Disabilities, Ministry of Social Justice & Empowerment organized a Natio

Researchers develop new therapy for metabolic liver disease

Editorial Article: Researchers develop a promising new therapy to tackle metabolic liver disease, NASH Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis 03 Aug 2021 Dr. Erik Tillman, Principal Scientist at Akero Therapeutics Non-alcohol related fatty liver disease (NAFLD) presents a global health crisis estimated to affect billions of people worldwide, including an estimated 100 million in the US alone 1. In this exclusive interview, we speak with Dr. Erik Tillman, Principal Scientist at Akero Therapeutics, to find out more about Akero’s pioneering work developing treatments for non-alcoholic steatohepatitis (NASH), a severe form of NAFLD that increases the risk for cardiovascular and liver-related morbidity and mortality. Tillman explains how he and his teammates are developing a multi-modal drug that may help treat the drivers of NASH and reverse liver scarring.  Tillman explains how his

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.